Pharmaceutical Industry Information Portal

HomeNews

News

New Russian vaccine Convacell can be registered before end of 1Q 2022

New Russian vaccine against the coronavirus, Convacell, can be registered before the end of the first quarter of 2022, head of the Federal Bio-Medical...

Walter Reed Army Institute of Research Continues Recruitment for COVID-19 Clinical Trial

The vaccine, called spike ferritin nanoparticle (SpFN), stands out in the COVID-19 vaccine landscape. Scientists developed a nanoparticle vaccine, based on a ferritin platform,...

ChemRar Group announces the Russian Avifavir® drug is effective against variants of COVID-19, including Delta and Omicron

ChemRar Group announces the Russian Avifavir® (INN: favipiravir) drug is effective against various variants of SARS-CoV-2 (coronavirus), including Delta and Omicron, as it affects...

FDA Authorizes Use of Oral Antiviral Molnupiravir for Mild to Moderate COVID-19

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the U.S. Food and Drug Administration (FDA) has...

Russian Ministry of Health registered Mir-19 anti-coronavirus drug

The Russian Ministry of Health registered the Mir-19 coronavirus pharmaceuticals developed by the Russian Federal Medical-Biological Agency (FMBA), the agency’s press service said. The press...

Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has authorized the emergency use of PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets)...
spot_img

Expert Articles

spot_img